Verrica Pharmaceuticals Inc. Common Stock (VRCA) is a publicly traded Healthcare sector company. As of July 21, 2026, VRCA trades at $5.49 with a market cap of $96.03M and a P/E ratio of -4.97. VRCA moved -0.18% today. Year to date, VRCA is -33.86%; over the trailing twelve months it is -32.75%. Its 52-week range spans $3.28 to $13.60. Analyst consensus is buy with an average price target of $16.00. Rallies surfaces VRCA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
3 analysts cover VRCA: 0 strong buy, 2 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $16.00.
| Metric | Value |
|---|---|
| Price | $5.49 |
| Market Cap | $96.03M |
| P/E Ratio | -4.97 |
| EPS | $-1.11 |
| Dividend Yield | 0.00% |
| 52-Week High | $13.60 |
| 52-Week Low | $3.28 |
| Volume | 6.74K |
| Avg Volume | 0 |
| Revenue (TTM) | $37.16M |
| Net Income | $-17.83M |
| Gross Margin | 0.00% |
3 analysts cover VRCA: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $16.00.